WeChat Mini Program
Old Version Features

Phase 1/2 Study of TP-3654, a Selective PIM1 Kinase Inhibitor: Preliminary Data Showed Clinical Activity and Cytokine Reductions in Relapsed/Refractory Myelofibrosis Patients

Lindsay A.M Rein,Firas El Chaer,Junichiro Yuda,Kazuya Shimoda,James McCloskey,Akiyoshi Takami,Tamanna Haque,Michiko Ichii,Shuichi Shirane,Masafumi Fukaya,Joseph M. Scandura,Terrence Bradley,Pankit Vachhani,Takayuki Tabayashi,Steven Green, Stanley Cheung,Prithviraj Bose,Sharad Khurana,Casey L. O'Connell,Idoroenyi Amanam

Blood（2023）

Cited 0|Views42
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined